300 related articles for article (PubMed ID: 16804707)
1. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
Lai TY; Ngai JW; Chan WM; Lam DS
Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
[TBL] [Abstract][Full Text] [Related]
2. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
Lai TY; Chan WM; Li H; Lai RY; Lam DS
Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
[TBL] [Abstract][Full Text] [Related]
3. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
[TBL] [Abstract][Full Text] [Related]
4. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
5. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
[TBL] [Abstract][Full Text] [Related]
7. Retinal disorders in northern Brazilian patients treated with chloroquine assessed by multifocal ERG.
Raster M; Horn F; Jünemann A; Rosa AA; Souza GS; Gomes BD; Lima MG; Silveira LC; Kremers J
Doc Ophthalmol; 2011 Apr; 122(2):77-86. PubMed ID: 21290166
[TBL] [Abstract][Full Text] [Related]
8. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
[TBL] [Abstract][Full Text] [Related]
9. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
[TBL] [Abstract][Full Text] [Related]
11. Assessing hydroxychloroquine toxicity by the multifocal ERG.
Moschos MN; Moschos MM; Apostolopoulos M; Mallias JA; Bouros C; Theodossiadis GP
Doc Ophthalmol; 2004 Jan; 108(1):47-53. PubMed ID: 15104166
[TBL] [Abstract][Full Text] [Related]
12. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
[TBL] [Abstract][Full Text] [Related]
13. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
14. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
15. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
16. Effect of stopping hydroxychloroquine therapy on the multifocal electroretinogram in patients with rheumatic disorders.
Adamptey B; Rudnisky CJ; MacDonald IM
Can J Ophthalmol; 2020 Feb; 55(1):38-44. PubMed ID: 31712033
[TBL] [Abstract][Full Text] [Related]
17. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
18. Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review : Review of mfERG ring ratios in Plaquenil toxicity.
Lyons JS; Severns ML
Doc Ophthalmol; 2009 Feb; 118(1):29-36. PubMed ID: 18465156
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
Adam MK; Covert DJ; Stepien KE; Han DP
Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
[TBL] [Abstract][Full Text] [Related]
20. Retina in rheumatic diseases: standard full field and multifocal electroretinography in hydroxychloroquine retinal dysfunction.
Nebbioso M; Livani ML; Steigerwalt RD; Panetta V; Rispoli E
Clin Exp Optom; 2011 May; 94(3):276-83. PubMed ID: 20533929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
